Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
424.00    -15.00 (-3.42%)
Bid:
426.00
Ask:
430.00
Spread: 4.00 (0.939%)
Market Cap: £208.53m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Third Quarter Trading Update

1 Nov 2017 07:00

RNS Number : 1767V
Zotefoams PLC
01 November 2017
 

Zotefoams plc

("Zotefoams" or the "Company" or "Group")

 

Trading Update

 

1st November 2017 - Zotefoams, a world leader in cellular materials technology, today provides a trading update for the third quarter ended 30 September 2017.

 

Zotefoams is pleased to report continued strong trading during the third quarter, maintaining the momentum of organic sales growth experienced in the first half of the year.

 

· Full year revenues expected to be ahead of market expectations

 

· Adjusted profit before tax and exceptional items for the year ending 31 December 2017 expected to be at the top end of the range of market expectations

 

· Group revenue 22% ahead for the third quarter against the comparative period

 

· Group revenue 24% ahead for the first nine months against the comparative period

 

In constant currency sales grew 16% in the third quarter following a 14% increase for the first six months of the year. The year-to-date growth has been delivered across all business units, with particularly strong growth in High-Performance Products, during the third quarter.

 

Management continues to invest in its strong portfolio of growth prospects and to manage the higher growth rates of early stage opportunities. The order book for the fourth quarter gives confidence that the Company will exceed market expectations for Group revenue and therefore, at current foreign exchange rates, the Board expects adjusted profit before tax and exceptional items for the year ending 31 December 2017 to be at the top end of the range of market expectations.

 

 

 

Commenting on the update David Stirling, Group CEO of Zotefoams, said: 

"We are delighted with the strong organic growth achieved across all business units during the third quarter of 2017. Our ambition is to establish ourselves as the world leader in cellular materials technology in our chosen markets. To achieve this ambition, we are investing significantly in new equipment and enhanced business capability. The Board is confident of another year of positive progress and about the long-term prospects for the business."

 

 

 

- Ends -

 

Enquiries:

 

Zotefoams plc

+44 (0) 208 664 1600

David Stirling, Group CEO

Gary McGrath, Group CFO

IFC Advisory

+44 (0) 203 053 8671

Graham Herring

Miles Nolan

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces and sells lightweight AZOTE® polyolefin and ZOTEK® high-performance foams for diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. In addition, Zotefoams owns and licenses patented MuCell® microcellular foam technology, developed specifically for extrusion applications, from a base in Massachusetts, USA to customers worldwide.

 

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT®).

 

www.zotefoams.com

 

AZOTE®, ZOTEK®, T-FIT® are registered trademarks of Zotefoams plc

MuCell® is a registered trademark of Trexel Inc.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUARWRBBAROAA
Date   Source Headline
13th Apr 20115:01 pmRNSNotice of AGM
4th Apr 201111:04 amRNSDirector/PDMR Shareholding
31st Mar 20113:04 pmRNSDirector/PDMR Shareholding
31st Mar 20117:00 amRNSAcquisition of MuCell and Share Placing
23rd Mar 20113:24 pmRNSDirector/PDMR Shareholding
8th Mar 20117:00 amRNSFinal Results
14th Feb 20113:47 pmRNSHolding(s) in Company
4th Jan 20113:00 pmRNSHolding(s) in Company
22nd Dec 20103:49 pmRNSHolding(s) in Company
21st Dec 20107:00 amRNSTrading Statement
16th Dec 201012:11 pmRNSHolding(s) in Company
2nd Dec 20109:32 amRNSDirectorate Change
17th Nov 20103:55 pmRNSHolding(s) in Company
17th Nov 20103:52 pmRNSHolding(s) in Company
12th Nov 20103:05 pmRNSDirector/PDMR Shareholding
22nd Oct 20107:00 amRNSInterim Management Statement
22nd Oct 20107:00 amRNSInterim Management Statement
12th Oct 20108:14 amRNSHolding(s) in Company
28th Sep 20105:41 pmRNSHolding(s) in Company
28th Sep 20105:39 pmRNSHolding(s) in Company
28th Sep 20101:00 pmRNSHolding(s) in Company
27th Sep 20103:02 pmRNSHolding(s) in Company
11th Aug 201010:57 amRNSHolding(s) in Company
9th Aug 20103:27 pmRNSHolding(s) in Company
3rd Aug 20107:00 amRNSHalf Yearly Report
1st Jul 20107:00 amRNSTrading Statement
9th Jun 201012:24 pmRNSHolding in company - amendment
9th Jun 201010:32 amRNSHolding(s) in Company
28th May 20103:31 pmRNSAnnual Information Update
17th May 20107:00 amRNSDirector/PDMR Shareholding
13th May 20103:00 pmRNSResult of AGM
11th May 20107:00 amRNSAGM Statement
7th May 20104:06 pmRNSDirector/PDMR Shareholding
12th Apr 20107:00 amRNSNotice of AGM
7th Apr 20104:30 pmRNSDirector/PDMR Shareholding
29th Mar 20108:50 amRNSHolding(s) in Company
24th Mar 201012:46 pmRNSHolding(s) in Company
23rd Mar 20102:40 pmRNSDirector/PDMR Shareholding
15th Mar 20104:52 pmRNSDirector/PDMR Shareholding
9th Mar 20107:00 amRNSFinal Results
3rd Mar 20102:36 pmRNSHolding(s) in Company
10th Dec 20092:30 pmRNSTrading Statement
23rd Oct 20097:00 amRNSInterim Management Statement
9th Oct 20093:08 pmRNSHolding(s) in Company
8th Sep 20092:13 pmRNSHolding(s) in Company
18th Aug 20091:36 pmRNSDirector/PDMR Shareholding
11th Aug 20095:45 pmRNSHolding(s) in Company
11th Aug 20095:15 pmRNSHolding(s) in Company
11th Aug 20094:19 pmRNSHolding(s) in Company
10th Aug 200912:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.